Massive recall of eye drops in the US
The FDA classified this recall as Class II, indicating that the use of these products could cause temporary adverse health consequences
The Food and Drug Administration (FDA) announced the voluntary recall of more than 3 million bottles of eye drops due to a lack of sterility assurance. The recall includes products sold at chains such as CVS, HEB, Kroger, Meijer, and Walgreens. The affected bottles were manufactured by KC Pharmaceuticals Inc. and marketed under various brand names. The FDA classified this recall as a Class II, indicating that the use of these products could cause temporary adverse health effects. List of affected bottles: The recall involves 3,111,072 bottles of different formulations, including: Distribution chain reactions: CVS confirmed to ABC News its cooperation in this process, stating that the product has been removed from its shelves and that measures have been implemented to prevent accidental sale. Consumers are also encouraged to return any purchased bottles for a refund. CVS also provided public notices regarding the recall, while KC Pharmaceuticals Inc. did not. ABC has not yet issued any additional statements.
Alternatives for Consumers
There are several safe alternatives to traditional eye drops, but they should always be evaluated by an ophthalmologist, because substituting certain eye drops (for example, for glaucoma) without supervision can put vision at risk.
For Dry Eye and Lubrication
For Intraocular Pressure (Glaucoma)
General Measures and Safe “Alternatives”
What to Avoid and When to See a Doctor

